This study will test an investigational drug, theophylline, in children with pseudohypoparathyroidism type 1a (PHP1a). This study involves a 3 day visit to the Vanderbilt Clinical Research Center.
Study measures will be done at baseline and during a 24h infusion of IV theophylline. Theophylline levels will be drawn to ensure therapeutic dosing and to monitor for toxicity. Measures include laboratory values, response to PTH infusion and resting energy expenditure.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
6
24 hour infusion of IV theophylline
Vanderbilt Unversity
Nashville, Tennessee, United States
Change in Urine cAMP
Change in urine cAMP (after parathyroid hormone stimulation) before and during treatment with theophylline
Time frame: 1 day
Change in Resting Energy Expenditure (REE)
Change in REE before and during treatment with theophylline
Time frame: 1 day
Change in Apnea Hypopnea Index (AHI)
Change in AHI before and during treatment with theophylline
Time frame: 1 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.